Daniela Toneatto

1 ta ish

GlaxoSmithKline (Italy)

1. 4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults

   Terry Nolan, Chiranjiwi Bhusal, Jiřı́ Beran +83

   MaqolaOAOchiq kirish20240 iqtibos

   ABIABI:AkademIndex/2024.article.018897